Skip to main content

PREPARACION FACILITADA DE COMPUESTOS QUIMICOS RELEVANTES EN BIOLOGIA

CTQ2015-67870-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structure-driven discovery of α,γ-diketoacid inhibitors against UL89 herpesvirus terminase

  • Bongarzone, Salvatore
  • Nadal, Marta
  • Kaczmarska, Zuzanna
  • Machón, Cristina
  • Álvarez, Mercedes
  • Albericio, Fernando
  • Coll, Miquel
This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes., Human cytomegalovirus (HCMV) is an opportunistic pathogen causing a variety of severe viral infections, including irreversible congenital disabilities. Nowadays, HCMV infection is treated by inhibiting the viral DNA polymerase. However, DNA polymerase inhibitors have several drawbacks. An alternative strategy is to use compounds against the packaging machinery or terminase complex, which is essential for viral replication. Our discovery that raltegravir (1), a human immunodeficiency virus drug, inhibits the nuclease function of UL89, one of the protein subunits of the complex, prompted us to further develop terminase inhibitors. On the basis of the structure of 1, a library of diketoacid (α,γ-DKA and β,δ-DKA) derivatives were synthesized and tested for UL89-C nuclease activity. The mode of action of α,γ-DKA derivatives on the UL89 active site was elucidated by using X-ray crystallography, molecular docking, and in vitro experiments. Our studies identified α,γ-DKA derivative 14 able to inhibit UL89 in vitro in the low micromolar range, making 14 an optimal candidate for further development and virus-infected cell assay., S.B. was supported by COFUND/Marie Curie fellowship (European Commission FP7). CM was supported by the RYC fellowship (grant RYC2011-09071) from the Ministerio de Economia y Competividad (MINECO). The Institute for Research in Biomedicine Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO. The work was partially supported by grants from the MINECO (grants BFU2011-22588, CTQ2012-30930, CTQ2015-67870P, BFU2014-53550-P, BFU2017-83720-P, Marí a de Maeztu Award of Excellence MDM-2014-0435), the Generalitat de Catalunya (grants 2014 SGR 1530 and 2014 SGR 137) and the European Commission FP7 (Project SILVER-GA no. 260644)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pseudo-Wang Handle for the Preparation of Fully Protected Peptides. Synthesis of Liraglutide by Fragment Condensation

  • Carbajo, Daniel
  • Fransen, Peter Paul K.H.
  • El-Faham, Ayman
  • Royo, Miriam
  • Albericio, Fernando
A handle for the protection of the C-terminus of peptides after cleaving with low concentration of trifluoroacetic acid (2-4%) is reported. The handle prevents polymerization reactions in the convergent condensation of peptidic fragments. Moreover, it is traceless, being removed during the final deprotection step of the peptide synthesis. This cheap and convenient handle is easily attached to the solid support, causing no disturbance to peptide elongation and thus proving to be useful in the convergent synthesis of long peptides. © 2019 American Chemical Society., This work was funded in part by the following: Lonza AG (Wisp, Switzerland), the Spanish Ministry of Economy, Industry, and Competitiveness (MINECO) (CTQ2015-67870-P & RTC-2014-2207-1), CIBER-BBN, the Generalitat de Catalunya (2017 SGR 1439) (Spain), and the International Scientific Partnership Program ISPP at King Saud University (ISPP# 0061) (Saudi Arabia)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Optimized Stepwise Synthesis of the API Liraglutide Using BAL Resin and Pseudoprolines

  • Carbajo, Daniel
  • El-Faham, Ayman
  • Royo, Miriam
  • Albericio, Fernando
The number of peptide-based active pharmaceutical ingredients (APIs) has increased enormously in recent years. Furthermore, the emerging new peptide drug candidates are more complex and larger. For the industrial solid-phase synthesis of C-carboxylic acid peptides, the two main resins available, Wang and chlorotrityl chloride (CTC), have a number of drawbacks. In this context, resins that form an amide bond with the first amino acid are more robust than Wang and CTC resins. Here, we address the use of the backbone (BAL) resin for the synthesis of the peptide liraglutide. The BAL resin, in conjunction with the use of pseudoprolines to avoid aggregation, allows the stepwise solid-phase synthesis of this API in excellent purity and yield. © 2019 American Chemical Society., Funding This work was funded in part by the following: Lonza AG (Visp, Switzerland), the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) (CTQ2015-67870-P and RTC-2014-2207-1), CIBER-BBN and the Generalitat de Catalunya (2017 SGR 1439) (Spain), and the International Scientific Partnership Program ISPP at King Saud University (ISPP# 0061) (Saudi Arabia). Notes The authors declare no competing financial interest., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis

  • Barth, Nicole D.
  • Subiros-Funosas, Ramón
  • Mendive-Tapia, Lorena
  • Duffin, Rodger
  • Shields, Mario A.
  • Cartwright, Jennifer A.
  • Henriques, Sónia Troeira
  • Sot, Jesús
  • Goñi, Félix M.
  • Lavilla, Rodolfo
  • Marwick, John A.
  • Vermeren, Sonja
  • Rossi, Adriano G.
  • Egeblad, Mikala
  • Dransfield, Ian
  • Vendrell, Marc
Programmed cell death or apoptosis is a central biological process that is dysregulated in many diseases, including inflammatory conditions and cancer. The detection and quantification of apoptotic cells in vivo is hampered by the need for fixatives or washing steps for non-fluorogenic reagents, and by the low levels of free calcium in diseased tissues that restrict the use of annexins. In this manuscript, we report the rational design of a highly stable fluorogenic peptide (termed Apo-15) that selectively stains apoptotic cells in vitro and in vivo in a calcium-independent manner and under wash-free conditions. Furthermore, using a combination of chemical and biophysical methods, we identify phosphatidylserine as a molecular target of Apo-15. We demonstrate that Apo-15 can be used for the quantification and imaging of drug-induced apoptosis in preclinical mouse models, thus creating opportunities for assessing the in vivo efficacy of anti-inflammatory and anti-cancer therapeutics., N.D.B. acknowledges funding from OPTIMA (EP/L016559/1). R.S.F. acknowledges an MSCA Individual Fellowship (659046). L.M.T. acknowledges the support of Fundacion Antonio Martin Escudero (FAME) in the form of a post-doctoral fellowship. S.T.H. is an Australian Research Council Future Fellow (FT150100398). R.L. acknowledges funding from MINECO (CTQ2015-67870-P and ERA NET PCIN-2015-224). F.M.G. acknowledges financial help from the Spanish Ministry of Economy (FEDER MINECO PGC2018-099857-B-I00) and the Basque Government (IT264-19). M.E. acknowledges funding from Cold Spring Harbor Laboratory Cancer Center (P30-CA045508), Northwell Health, and the Thompson Family Foundation. M.V. acknowledges funding from an ERC Consolidator Grant (771443), the Biotechnology and Biological Sciences Research Council (BB/M025160/1), and The Royal Society (RG160289)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Trp-BODIPY cyclic peptide for fluorescence labelling of apoptotic bodies

  • Subiros-Funosas, Ramón
  • Mendive-Tapia, Lorena
  • Sot, Jesús
  • Pound, John D.
  • Barth, Nicole D.
  • Varela, Yaiza R.
  • Goñi, Félix M.
  • Paterson, Margaret
  • Gregory, Christopher D
  • Albericio, Fernando
  • Dransfield, Ian
  • Lavilla, Rodolfo
  • Vendrell, Marc
This article is part of the themed collection: Biological optical imaging, The rational design and synthesis of a Trp-BODIPY cyclic peptide for the fluorescent labelling of apoptotic bodies is described. Affinity assays, confocal microscopy and flow cytometry analysis confirmed the binding of the peptide to negatively-charged phospholipids associated with apoptosis, and its applicability for the detection and characterisation of subcellular structures released by apoptotic cells., R. S.-F. acknowledges a MSCA Individual Fellowship (659046). L. M.-T. acknowledges a FPU Scholarship (MECD-Spain). F. M. G. acknowledges FEDER-Mineco (BFU 2015-66306-P) and the Basque Gov. (IT849-13). R. L. acknowledges DGICYT-Spain (BQU-CTQ2015-67870-P) and Generalitat de Catalunya (2014 SGR 137). C. D. G., J. D. P. and M. P. acknowledge Bloodwise. M. V. acknowledges the Medical Research Council, the Marie Curie Integration Grant (333847), and the Biotechnology and Biological Sciences Research Council (BB/M025160/1)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Hydroxylamine derivatives as a new paradigm in the search of antibacterial agents

  • Miret-Casals, Laia
  • Baelo, Aida
  • Julián, Esther|||0000-0002-6558-3978
  • Astola, Josep
  • Lobo-Ruiz, Ariadna
  • Albericio, Fernando|||0000-0002-8946-0462
  • Torrents, Eduard|||0000-0002-3010-1609
Serious infections caused by bacteria that are resistant to commonly used antibiotics have become a major global healthcare problem in the 21st century. Multidrug-resistant bacteria causing severe infections mainly grow in complex bacterial communities known as biofilms, in which bacterial resistance to antibacterial agents and to the host immune system is strengthened. As drug resistance is becoming a threatening problem, it is necessary to develop new antimicrobial agents with novel mechanisms of action. Here, we designed and synthesized a small library of N -substituted hydroxylamine (N-HA) compounds with antibacterial activity. These compounds, acting as radical scavengers, inhibit the bacterial ribonucleotide reductase (RNR) enzyme. RNR enzyme is essential for bacterial proliferation during infection, as it provides the building blocks for DNA synthesis and repair. We demonstrate the broad antimicrobial effect of several drug candidates against a variety of Gram-positive and Gram-negative bacteria, together with low toxicity toward eukaryotic cells. Furthermore, the most promising compounds can reduce the biomass of an established biofilm on Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli. This study settles the starting point to develop new N -hydroxylamine compounds as potential effective antibacterial agents to fight against drug-resistant pathogenic bacteria.